Literature DB >> 11024334

Federal immunization policy and funding: a history of responding to crises.

K A Johnson1, A Sardell, B Richards.   

Abstract

BACKGROUND: This article outlines the history of federal immunization policy and funding, with a focus on discretionary federal funding under Section 317 of the Public Health Service Act, paying particular attention to the role of Congress in shaping the program in the past 2 decades. This review of funding trends and initiatives indicates that when both a presidential administration and key congressional actors viewed immunization as a priority and made sufficient funds available to support the public health delivery system and its infrastructure, coverage levels would continue to rise and disease levels continue to decline. From the beginning, immunization financing was explicitly structured as a federal-state-private-sector partnership. Section 317 program's statute has not changed much in 35 years, despite significant changes to the health care delivery system, other federal immunization activities, and rates of immunization coverage. Although the creation and implementation of the Vaccines for Children (VFC) program in the mid-1990s resulted in some congressional deliberations over immunization policies, no explicit restructuring of the 317 program occurred as a result. The Section 317 program retains its traditional authority and mission to address urgent needs, sustain public delivery systems, and provide funds for purchase of vaccines. The question remains whether the resources to sustain progress in immunization can be secured during times with no crisis, to ensure constant "readiness" in immunization (as in defense), or whether another epidemic must occur before the federal government is willing to commit optimal resources.

Entities:  

Mesh:

Year:  2000        PMID: 11024334     DOI: 10.1016/s0749-3797(00)00210-5

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  6 in total

1.  Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage.

Authors:  David B Rein; Amanda A Honeycutt; Lucia Rojas-Smith; James C Hersey
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

2.  Immunity for the people: the challenge of achieving high vaccine coverage in American history.

Authors:  James Colgrove
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

3.  Timing of Clinical Billing Reimbursement for a Local Health Department.

Authors:  J Mac McCullough
Journal:  Public Health Rep       Date:  2016 Mar-Apr       Impact factor: 2.792

Review 4.  Costs and financial feasibility of malaria elimination.

Authors:  Oliver Sabot; Justin M Cohen; Michelle S Hsiang; James G Kahn; Suprotik Basu; Linhua Tang; Bin Zheng; Qi Gao; Linda Zou; Allison Tatarsky; Shahina Aboobakar; Jennifer Usas; Scott Barrett; Jessica L Cohen; Dean T Jamison; Richard G A Feachem
Journal:  Lancet       Date:  2010-10-28       Impact factor: 79.321

5.  Racial and ethnic disparities in H1N1 vaccine uptake in Medicaid: Lessons learned for a COVID-19 vaccine rollout.

Authors:  Chaohua Li; Megan Douglas; Rabab Zahidi; Robina Josiah Willock; Lee Caplan; Peter Baltrus; Eric Gillis; Dominic Mack; Anne Gaglioti
Journal:  Prev Med Rep       Date:  2021-10-06

6.  Rates of coverage and determinants of complete vaccination of children in rural areas of Burkina Faso (1998-2003).

Authors:  Drissa Sia; Pierre Fournier; Jean-François Kobiané; Blaise K Sondo
Journal:  BMC Public Health       Date:  2009-11-17       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.